Aortic Valve Stenosis Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
62 |
Global |
$2,500.00 |
|
Thrombophlebitis Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
42 |
Global |
$2,500.00 |
|
Retinoblastoma Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
72 |
Global |
$2,500.00 |
|
Intermittent Claudication Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
82 |
Global |
$2,500.00 |
|
Refractory Angina Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
32 |
Global |
$2,500.00 |
|
Recurrent Medulloblastoma Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
55 |
Global |
$2,500.00 |
|
Restenosis Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
77 |
Global |
$2,500.00 |
|
Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
290 |
Global |
$2,500.00 |
|
Bacterial Endocarditis Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
37 |
Global |
$2,500.00 |
|
Malignant Glioma Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
264 |
Global |
$2,500.00 |
|
Systolic Hypertension Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
68 |
Global |
$2,500.00 |
|
Chronic Thromboembolic Pulmonary Hypertension Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
59 |
Global |
$2,500.00 |
|
Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
104 |
Global |
$2,500.00 |
|
Pericarditis Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
31 |
Global |
$2,500.00 |
|
Arterial Stiffness Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
70 |
Global |
$2,500.00 |
|
Non-Rhabdomyosarcoma Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
181 |
Global |
$2,500.00 |
|
Papillary Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
65 |
Global |
$2,500.00 |
|
Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
47 |
Global |
$2,500.00 |
|
Atherosclerosis Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
467 |
Global |
$2,500.00 |
|
Pontine Glioma Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
74 |
Global |
$2,500.00 |
|
Urinary Tract Cancer Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
2014 |
Global |
$2,500.00 |
|
Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
44 |
Global |
$2,500.00 |
|
Acute Heart Failure Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
131 |
Global |
$2,500.00 |
|
Metastatic Breast Cancer Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
1889 |
Global |
$2,500.00 |
|
Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
431 |
Global |
$2,500.00 |
|
Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
56 |
Global |
$2,500.00 |
|
Arteriosclerosis Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
532 |
Global |
$2,500.00 |
|
Supraventricular Tachycardia Global Clinical Trials Review, H2, 2016 |
Jul 29 2016 |
41 |
Global |
$2,500.00 |
|
Spinal Muscular Atrophy (SMA) Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
73 |
Global |
$2,500.00 |
|
Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
39 |
Global |
$2,500.00 |
|